Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia

L Pagano; G Morace; E Ortu-La Barbera; M Sanguinetti; G Leone

doi:10.1007/s002770050196

Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia

Ann Hematol. 1996 Jul;73(1):33-4. doi: 10.1007/s002770050196.

Authors

L Pagano¹, G Morace, E Ortu-La Barbera, M Sanguinetti, G Leone

Affiliation

¹ Istituto di Semeiotica Medica, Università Cattolica del Sacro Cuore, Rome, Italy.

PMID: 8695721
DOI: 10.1007/s002770050196

Abstract

We report a patient with acute myeloid leukemia and Blastoschizomyces capitatus sepsis who developed multiple abscesses when neutrophils recovered. The patient did not respond to antifungal therapy and her clinical condition showed an improvement only after rhGM-CSF was added to the treatment.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Acute Disease
Aged
Female
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
Humans
Leukemia, Myeloid / drug therapy*
Mycoses / drug therapy*
Mycoses / immunology
Neutropenia / drug therapy
Neutrophils / immunology
Opportunistic Infections / drug therapy*
Recombinant Proteins

Substances

Recombinant Proteins
Granulocyte-Macrophage Colony-Stimulating Factor